New study explores what matters most to patients with high-risk head and neck skin cancer
NCT ID NCT05482880
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how 78 patients with high-risk skin cancer on the head or neck felt about their treatment decisions, quality of life, and satisfaction with care. Researchers used standard questionnaires to measure these factors at two points: right after a team of doctors discussed the case, and one month after treatment ended. The goal was to better understand what patients experience during this complex care process.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
78 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients are selected by the treating physicians from multidisciplinary consultation in the secondary/tertiary centers Maastricht UMC+ and Radboud UMC.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients diagnosed with a cutaneous squamous cell carcinoma located in the head-neck area (including patients with metastatic or recurrence disease) * requiring a multidisciplinary approach * assessed at the department of dermatology of Maastricht UMC+ or Radboud UMC OR discussed in the multidisciplinary consultation in Maastricht UMC+ or Radboud UMC * and for which treatment of the tumor (primary tumor or metastatic/recurrence) takes places in the Maastricht UMC+ of Radboud UMC * willing to participate voluntarily in the study Exclusion Criteria: * patients younger than 18 years * patients with inadequate understanding of the Dutch language * patients with cognitive impairment or otherwise unable to complete the questionnaires
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cutaneous squamous cell carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maastricht University Medical Center +
Maastricht, Limburg, Netherlands
-
Radboud UMC
Nijmegen, Gelderland, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart Disease's hidden toll: study tracks quality of life across mind, body, and spirit
- 150,000 children to be tracked from birth to old age in massive health study
- Can a website help liver cancer patients care for themselves during chemoembolization?
- Shorter radiation course tested for advanced head and neck cancer
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care
- Fewer dialysis sessions: can Twice-Weekly work as well?